Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

PROPOFLO 28 - Health Canada Drug Approval Details

Approvals/Health Canada/PROPOFLO 28

Authorized

STANDARD

PROPOFLO 28

ZOETIS CANADA INC🇨🇦 Health Canada

Approval Date: Apr 6, 2026
Approval ID: cc6aab2ee65777b6
Company: ZOETIS CANADA INC
Type: Standard

Approval Details

Approval Id: cc6aab2ee65777b6
Drug Approval Canada Name: PROPOFLO 28
Product Name: PROPOFLO 28
Status: Marketed
Status Date: 2016-08-26
Original Market Date: 2016-08-26
Din: 02445654
Drug Class: Veterinary
Dosage Form: Solution
Route Of Administration: Intravenous
Schedule: PRESCRIPTION
Atc Original: Not Applicable
Aig Number: 0121833001
Company Name: ZOETIS CANADA INC
Company Address: 16740 Trans Canada Highway Kirkland Quebec Canada H9H 4M7

Authorized

Quick Info

Agency

Health Canada

Country

🇨🇦

Approval Date

Apr 6, 2026

Approval ID

cc6aab2ee65777b6

Type

Standard

Back to Health Canada Approvals